Western blot results were consistent with immunohistochemical analysis, with stroke elevating GFAP levels and CORT administration suppressing them (sham FC = 1 vs. stroke FC = 2.5, p < 0.001; stroke vs. stroke CORT FC = 1.004, p < 0.05, Figure 4B). The gene discussed is GFAP; the disease is Stroke.